DRKS00024819已完成未知
Prospective, monocentric clinical study about the effect of a novel technique for mucus mobilization on lung function, mucus viscosity and diaphragmatic mobility in cystic fibrosis patients - SekMobi-1
lm University Medical Center0 个研究点目标入组 21 人开始时间: 2021年4月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 64 Years（—）
- 性别
- All
入选标准
- •diagnosed cystic fibrosis
排除标准
- •- acute infection
- •- reduced general condition
- •- massive hemoptysis within the last 4 weeks
- •- pneumothorax within the last 6 weeks
- •- uncontrolled asthmatic symptoms
- •- unstable cardiovascular disease
- •- unstable pulmonary situation with dyspnea
- •- pregnancy
研究者
相似试验
尚未招募
不适用
Clinical study ofacne mastitisITMCTR2200006068Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine
已完成
不适用
Prospective, randomized, monocentric study for the determination of device-related dead spaces under controlled ventilation under general anesthesiaSpine operations in prone positionDRKS00015797St. Josef- und St. Elisabeth- Hospital gGmbH Klinik für Anästhesiologie und operative Intensivmedizin34
已完成
不适用
Prospective, randomized, monocentric study for the determination of device-related dead spaces in the MIRUS-System under controlled ventilation under general anesthesiaGeneral anaesthesia for orthopaedic surgeryJ80J44Adult respiratory distress syndromeOther chronic obstructive pulmonary diseaseDRKS00021648Katholisches Klinikum gGmbH, Klinik für Anästhesiologie und operative Intensivmedizin40
尚未招募
Unknown
A prospective, single-center investigation of the safety and feasibility of a novel Microwave Ablation SystemC34C78.0Malignant neoplasm of bronchus and lungSecondary malignant neoplasm of lungDRKS00032463Intuitive Surgical30
进行中（未招募）
1 期
Study to investigate the effect of riociguat on right heart size and function in pulmonary hypertensioSymptomatic pulmonary arterial hypertension with a mean pulmonary artery pressure >20 mmHg and pulmonary vascular resistance =2 Wood Units, pulmonary arterial wedge pressure =15 mmHg (Group I / Nice Clinical Classification of Pulmonary Hypertension (PH)) or CTEPH (Group IV) with hemodynamics as stated above defined as inoperable measured at least 3 months after start of full anticoagulation or with persisting or recurrent PH after pulmonary endarterectomy at least 6 months after surgeryMedDRA version: 20.0Level: HLTClassification code 10037401Term: Pulmonary hypertensionsSystem Organ Class: 100000004855EUCTR2020-005462-34-DEThoraxklinik Heidelberg gGmbH30